Showing results (1011-1020 of 3,615) with videos related to
Sort By:
Pageof 362
Journal of Viral Hepatitis|January 25, 2022
Evolutionary characteristics and immune mutation of hepatitis C virus genotype 1b among intravenous drug users in mainland, ChinaSheng Wu, Huangbo Yuan, Hong Fan, et al.Journal of Viral Hepatitis|January 13, 2001
Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatmentM Gürsoy, G Gür, H Arslan, et al.Journal of Viral Hepatitis|December 15, 2000
Retreatment for 24 vs 48 weeks with interferon-alpha2b plus ribavirin of chronic hepatitis C patients who relapsed or did not respond to interferon aloneJ Enríquez, A Gallego, X Torras, et al.Journal of Viral Hepatitis|December 15, 2000
Sequence, expression and reconstitution of an HCV genome from a British isolate derived from a single blood donationU Kumar, T Tuthill, H C Thomas, et al.Journal of Viral Hepatitis|January 3, 2023
DDX3-mediated miR-34 expression inhibits autophagy and HBV replication in hepatic cellsAmit Kumar Mishra, Md Musa Hossain, Mohd Umar, et al.Journal of Viral Hepatitis|January 3, 2026
Outcomes and Survival of Egyptian Patients With Hepatitis B-Related Hepatocellular Carcinoma: A Multicentre Retrospective StudyEman M F Barakat, Mohamed Kohla, Ahmed Tawheed, et al.Journal of Viral Hepatitis|January 3, 2026
Characteristics of Newly Reported Chronic Hepatitis C Cases Among Adults in the United States, 2016-2023: Insights From Population-Based SurveillanceShaoman Yin, Megan G Hofmeister, Nicola D Thompson, et al.Journal of Viral Hepatitis|September 1, 1996
Prolonged therapy of chronic hepatitis C with ribavirinJ H Hoofnagle, D Lau, H Conjeevaram, et al.Journal of Viral Hepatitis|September 1, 1996
Detectable levels of IgM antibodies to hepatitis C virus core protein predict breakthrough in patients with chronic hepatitis C treated with interferon-alphaO Fracassetti, R Tambini, V Perani, et al.Journal of Viral Hepatitis|May 1, 1996
The use of deferoxamine infusions to enhance the response rate to interferon-alpha treatment of chronic viral hepatitis BY Bayraktar, T Koseoglu, C Somner, et al.Pageof 362